Science Explorer Back to mapMap
Discussion
Researcher · GW Pharmaceuticals (United Kingdom) · United Kingdom

Graeme C.M. Smith

Graeme C.M. Smith publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as DNA Repair Mechanisms, PARP inhibition in cancer therapy and Cancer therapeutics and mechanisms.

ORCID 0000-0001-8320-4057 OpenAlex
World rank
#100,996
of 7,710,434 ranked researchers
Rank in United Kingdom
#8,883
of 367,258
Works
186
Citations
21k
Citations per work
114.3
h-index
47
i10-index 60Top 4.5% in Molecular Biology
Graeme C.M. Smith

What does Graeme C.M. Smith research?

Graeme C.M. Smith's work is mostly in Biochemistry, Genetics and Molecular Biology (50%), Medicine (20%), Chemistry (4%).

Life Sciences: 99 works · 53.4% of their workBiochemistry, Genetics and Molecular Biology: 94 works · 50.5% of their workMolecular Biology: 80 works · 43.1% of their workCancer Research: 8 works · 4.5% of their workCell Biology: 5 works · 2.9% of their workImmunology and Microbiology: 5 works · 2.9% of their workImmunology: 5 works · 2.9% of their workEverything else: 41 works · 22.1% of their workHealth Sciences: 38 works · 20.3% of their workMedicine: 38 works · 20.3% of their workOncology: 38 works · 20.3% of their workPhysical Sciences: 8 works · 4.2% of their workChemistry: 8 works · 4.2% of their workOrganic Chemistry: 8 works · 4.2% of their workTHEIR WORKGraeme C.M. Smith186works
Life Sciences53%Physical Sciences4%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology9450.5%
    2. Immunology and Microbiology52.9%
  2. Everything else4122.1%
    1. Medicine3820.3%
    1. Chemistry84.2%
  1. 1Molecular Biology43% of their works
  2. 2Oncology20% of their works
  3. 3Cancer Research4% of their works
  4. 4Organic Chemistry4% of their works
  5. 5Immunology3% of their works
  6. 6Cell Biology3% of their works

Research topics

Which keywords describe Graeme C.M. Smith's research?

The keywords of their largest research topics: Homologous Recombination, DNA Damage, Genomic Instability, Repair, Cancer Therapy, BRCA Mutation, PARP Inhibitors and DNA.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Homologous Recombination912 topics
  2. DNA Damage642 topics
  3. Genomic Instability581 topic
  4. Repair581 topic
  5. Cancer Therapy553 topics
  6. BRCA Mutation331 topic
  7. PARP Inhibitors331 topic
  8. DNA271 topic
  9. Topoisomerases271 topic
  10. Apoptosis232 topics
  11. Genome Engineering161 topic
  12. RNA-Guided161 topic
  13. Cell Cycle151 topic
  14. p53151 topic
  15. Quinones81 topic
  16. Toxicology81 topic
  17. Cell Division71 topic
  18. Microtubules71 topic
  19. Comet Assay61 topic
  20. Genotoxicity Testing61 topic

Where does Graeme C.M. Smith work?

Graeme C.M. Smith's main affiliation in the publication record is GW Pharmaceuticals (United Kingdom), United Kingdom.

How many publications and citations does Graeme C.M. Smith have?

OpenAlex counts 186 works and 21,260 citations for Graeme C.M. Smith, an h-index of 47, ranking #100,996 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Graeme C.M. Smith. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.